Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Neurosci Bull. 2018 Apr;34(2):369-381. doi: 10.1007/s12264-017-0192-4. Epub 2017 Nov 24.
Our previous studies proposed that Alzheimer's disease (AD) is a metabolic disorder and hypothesized that abnormal brain glucose metabolism inducing multiple pathophysiological cascades contributes to AD pathogenesis. Aging is one of the great significant risk factors for AD. Membrane aging is first prone to affect the function and structure of the brain by impairing glucose metabolism. We presume that risk factors of AD, including genetic factors (e.g., the apolipoprotein E ε4 allele and genetic mutations) and non-genetic factors (such as fat, diabetes, and cardiac failure) accelerate biomembrane aging and lead to the onset and development of the disease. In this review, we further modify our previous hypothesis to demonstrate "membrane aging" as an initial pathogenic factor that results in functional and structural alterations of membranes and, consequently, glucose hypometabolism and multiple pathophysiological cascades.
我们之前的研究提出,阿尔茨海默病(AD)是一种代谢紊乱,并假设异常的大脑葡萄糖代谢引发的多种病理生理级联反应导致 AD 的发病机制。衰老 是 AD 的一个重要危险因素。膜衰老首先通过损害葡萄糖代谢而容易影响大脑的功能和结构。我们推测 AD 的危险因素,包括遗传因素(例如载脂蛋白 E ε4 等位基因和基因突变)和非遗传因素(如脂肪、糖尿病和心力衰竭),加速生物膜衰老,导致疾病的发生和发展。在这篇综述中,我们进一步修改了之前的假设,以证明“膜衰老”作为一个初始的致病因素,导致膜的功能和结构改变,进而导致葡萄糖代谢不足和多种病理生理级联反应。